The most effective new drugs for serious diseases such as cancer or cystic fibrosis are approved throughout the EU. But they are by no means available everywhere in the EU: Why the pharmaceutical industry can play poor countries off against rich ones, what Germany has to do with it – and how a three-year-old girl from Lithuania is suffering as a result.